ENTRADA THERAPEUTICS INC. - COMMON STOCK
11.22
12-3月-25 16:45:01
15 分の遅延
株式
+0.57
+5.35%
本日の幅
10.64 - 11.27
ISIN
N/A
ソース
NASDAQ
-
Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer
19 7 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at William Blair Biotech Focus Conference
06 7 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at Goldman Sachs Global Healthcare Conference
01 6 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports First Quarter 2022 Financial Results
12 5 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
11 5 2022 09:30:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at H.C. Wainwright Global Investment Conference
10 5 2022 07:00:03 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
15 3 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics to Participate in Cowen 42nd Annual Health Care Conference
23 2 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics Announces the Appointment of Jared Cohen, PhD, JD to General Counsel
05 1 2022 08:00:03 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics to be Added to Russell 2000® and Russell 3000® Indexes
17 12 2021 08:00:00 提供 Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Third Quarter 2021 Financial Results
09 12 2021 07:00:00 提供 Nasdaq GlobeNewswire